Clinical trial
IVIG Versus Plasmapheresis and Guillian Barrie Syndrome
NCT05104762 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IVIG Versus Plasmapheresis and Guillian Barrie Syndrome
- Lead sponsor
- Assiut University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- March 3, 2023
- Enrollment
- 81 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.